Andrew Witty

Andrew Witty is the CEO and Director of pharmaceutical company Glaxo Smith Kline and was paid £2.03 million in 2010. He is also a board member of the Pharmaceutical Research and Manufacturers of America (PhRMA). Both Glaxo Smith Kline and PhRMA are represented on the American Legislative Exchange Council (ALEC).

Ties to American Legislative Exchange Council
Glaxo Smith Kline and PhRMA are represented on the Corporate ("Private Enterprise") Board of the American Legislative Exchange Council (ALEC), as of 2011.

Background
Before becoming CEO in 2008, Witty was the President of Pharmaceuticals Europe.

Pharmaceuticals Europe
GlaxoSmithKline (GSK) is an international pharmaceutical giant headquartered in Britain. Various entities, including Burroughs Wellcome & Company, Smith-Kline & French Laboratories and Glaxo Laboratories merged to form GSK. GSK is one of the top five drug firms in the world.

GSK
In the fiscal year ending in December of 2010, the company earned a total revenues of approximately $28.4 billion dollars and employed 99,913 workers. Its CEO, Andrew Witty, made an annual compensation of $2.3 GB in 2010.